Allarity Therapeutics, Inc. (ALLR): Total Liabilities
$8.43M
As of 2025-12-31
$28.58M
As of 2026-06-30
-12.7%
3-year compound annual growth
-1.2%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.43M | -22.2% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $10.84M | -25.8% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $14.61M | +15.5% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $12.65M | -59.0% | 2024-03-08, Balance as of period end |
| 2021-12-31 | $30.85M | +244.1% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $8.96M | n/a | 2022-05-17, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.43M | -22.2% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $2.74M | -52.6% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $7.00M | +0.4% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $7.76M | +13.9% |
| America Great Health (AAGH) | 2025-06-30 | $6.05M | +11.0% |
| Medicinova Inc (MNOV) | 2025-12-31 | $4.02M | +19.1% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $14.06M | -45.5% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $6.56M | +21.9% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $5.00M | -67.6% |
Compare ALLR, HIND, PVCT, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗